Delivra Health Brands Inc. (DHB.V)

CAD 0.02

(0.0%)

Net Debt Summary of Delivra Health Brands Inc.

  • Delivra Health Brands Inc.'s latest annual net debt in 2023 was -2.17 Million CAD , down -184.42% from previous year.
  • Delivra Health Brands Inc.'s latest quarterly net debt in 2023 Q4 was -2.17 Million CAD , down -57.01% from previous quarter.
  • Delivra Health Brands Inc. reported annual net debt of -764 Thousand CAD in 2022, down -174.68% from previous year.
  • Delivra Health Brands Inc. reported annual net debt of 1.02 Million CAD in 2021, up 145.09% from previous year.
  • Delivra Health Brands Inc. reported quarterly net debt of -1.38 Million CAD for 2023 Q3, down -27.68% from previous quarter.
  • Delivra Health Brands Inc. reported quarterly net debt of -1.08 Million CAD for 2023 Q2, down -15.69% from previous quarter.

Annual Net Debt Chart of Delivra Health Brands Inc. (2023 - 2015)

Historical Annual Net Debt of Delivra Health Brands Inc. (2023 - 2015)

Year Net Debt Net Debt Growth
2023 -2.17 Million CAD -184.42%
2022 -764 Thousand CAD -174.68%
2021 1.02 Million CAD 145.09%
2020 -2.26 Million CAD -149.68%
2019 4.56 Million CAD 122.77%
2018 -20.06 Million CAD 64.71%
2017 -56.84 Million CAD -299.02%
2016 -14.24 Million CAD -29673.5%
2015 -47.84 Thousand CAD 0.0%

Peer Net Debt Comparison of Delivra Health Brands Inc.

Name Net Debt Net Debt Difference
Aequus Pharmaceuticals Inc. 4.89 Million CAD 144.405%
CanadaBis Capital Inc. 4.08 Million CAD 153.206%
Decibel Cannabis Company Inc. 37.48 Million CAD 105.797%
Entourage Health Corp. 150.32 Million CAD 101.446%
Lifeist Wellness Inc. -188.12 Thousand CAD -1055.058%
Cannara Biotech Inc. 41.51 Million CAD 105.235%
Medicure Inc. -5.82 Million CAD 62.695%
PharmaCielo Ltd. 18.24 Million CAD 111.909%
Rubicon Organics Inc. 475.37 Thousand CAD 557.116%
BioSyent Inc. -3.68 Million CAD 41.031%
Voyageur Pharmaceuticals Ltd. 37.91 Thousand CAD 5831.241%